BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 29316905)

  • 1. App-technology to increase physical activity among patients with diabetes type 2 - the DiaCert-study, a randomized controlled trial.
    Bonn SE; Alexandrou C; Hjörleifsdottir Steiner K; Wiklander K; Östenson CG; Löf M; Trolle Lagerros Y
    BMC Public Health; 2018 Jan; 18(1):119. PubMed ID: 29316905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. App-technology to improve lifestyle behaviors among working adults - the Health Integrator study, a randomized controlled trial.
    Bonn SE; Löf M; Östenson CG; Trolle Lagerros Y
    BMC Public Health; 2019 Mar; 19(1):273. PubMed ID: 30845949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digital Support for Healthier Eating Habits Among Patients With Type 2 Diabetes: Protocol for a Randomized Clinical Trial Within Primary Care (HAPPY Trial).
    Trolle Lagerros Y; Dahlgren A; Sjöblom L; Bonn SE
    JMIR Res Protoc; 2020 Nov; 9(11):e24422. PubMed ID: 33196448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of the smartphone app DiaCert on health related quality of life in patients with type 2 diabetes: results from a randomized controlled trial.
    Hummel M; Bonn SE; Trolle Lagerros Y
    Diabetol Metab Syndr; 2022 Dec; 14(1):192. PubMed ID: 36528609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Outcomes Among Working Adults Using the Health Integrator Smartphone App: Analyses of Prespecified Secondary Outcomes in a Randomized Controlled Trial.
    Bonn S; Licitra G; Bellocco R; Trolle Lagerros Y
    J Med Internet Res; 2022 Mar; 24(3):e24725. PubMed ID: 35311677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MINISTOP 2.0: a smartphone app integrated in primary child health care to promote healthy diet and physical activity behaviours and prevent obesity in preschool-aged children: protocol for a hybrid design effectiveness-implementation study.
    Henriksson H; Alexandrou C; Henriksson P; Henström M; Bendtsen M; Thomas K; Müssener U; Nilsen P; Löf M
    BMC Public Health; 2020 Nov; 20(1):1756. PubMed ID: 33228572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The HealtheSteps™ lifestyle prescription program to improve physical activity and modifiable risk factors for chronic disease: a pragmatic randomized controlled trial.
    Gill DP; Blunt W; Boa Sorte Silva NC; Stiller-Moldovan C; Zou GY; Petrella RJ
    BMC Public Health; 2019 Jun; 19(1):841. PubMed ID: 31253112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a Smartphone App on Weight Change and Metabolic Outcomes in Asian Adults With Type 2 Diabetes: A Randomized Clinical Trial.
    Lim SL; Ong KW; Johal J; Han CY; Yap QV; Chan YH; Chooi YC; Zhang ZP; Chandra CC; Thiagarajah AG; Khoo CM
    JAMA Netw Open; 2021 Jun; 4(6):e2112417. PubMed ID: 34081137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BetaMe: impact of a comprehensive digital health programme on HbA1c and weight at 12 months for people with diabetes and pre-diabetes: study protocol for a randomised controlled trial.
    Sarfati D; McLeod M; Stanley J; Signal V; Stairmand J; Krebs J; Dowell A; Leung W; Davies C; Grainger R
    Trials; 2018 Mar; 19(1):161. PubMed ID: 29506562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Mobile Lifestyle Management Program (GlycoLeap) for People With Type 2 Diabetes: Single-Arm Feasibility Study.
    Koot D; Goh PSC; Lim RSM; Tian Y; Yau TY; Tan NC; Finkelstein EA
    JMIR Mhealth Uhealth; 2019 May; 7(5):e12965. PubMed ID: 31127720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobile App for Improved Self-Management of Type 2 Diabetes: Multicenter Pragmatic Randomized Controlled Trial.
    Agarwal P; Mukerji G; Desveaux L; Ivers NM; Bhattacharyya O; Hensel JM; Shaw J; Bouck Z; Jamieson T; Onabajo N; Cooper M; Marani H; Jeffs L; Bhatia RS
    JMIR Mhealth Uhealth; 2019 Jan; 7(1):e10321. PubMed ID: 30632972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of a Lifestyle Intervention Supported by the InterWalk Smartphone App on Increasing Physical Activity Among Persons With Type 2 Diabetes: Parallel-Group, Randomized Trial.
    Thorsen IK; Yang Y; Valentiner LS; Glümer C; Karstoft K; Brønd JC; Nielsen RO; Brøns C; Christensen R; Nielsen JS; Vaag AA; Pedersen BK; Langberg H; Ried-Larsen M
    JMIR Mhealth Uhealth; 2022 Sep; 10(9):e30602. PubMed ID: 36170002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Wearable Technology Delivering a Web-Based Diabetes Prevention Program to People at High Risk of Type 2 Diabetes: Randomized Controlled Trial.
    Staite E; Bayley A; Al-Ozairi E; Stewart K; Hopkins D; Rundle J; Basudev N; Mohamedali Z; Ismail K
    JMIR Mhealth Uhealth; 2020 Jul; 8(7):e15448. PubMed ID: 32459651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mobile Exergaming for Health-Effects of a serious game application for smartphones on physical activity and exercise adherence in type 2 diabetes mellitus-study protocol for a randomized controlled trial.
    Höchsmann C; Walz SP; Schäfer J; Holopainen J; Hanssen H; Schmidt-Trucksäss A
    Trials; 2017 Mar; 18(1):103. PubMed ID: 28264717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An automated structured education intervention based on a smartphone app in Chinese patients with type 1 diabetes: a protocol for a single-blinded randomized controlled trial.
    Huang F; Wu X; Xie Y; Liu F; Li J; Li X; Zhou Z
    Trials; 2020 Nov; 21(1):944. PubMed ID: 33225982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for a clinical trial of text messaging in addition to standard care versus standard care alone in prevention of type 2 diabetes through lifestyle modification in India and the UK.
    Thomson H; Oliver N; Godsland IF; Darzi A; Srivanichakorn W; Majeed A; Johnston DG; Nanditha A; Snehalatha C; Raghavan A; Susairaj P; Simon M; Satheesh K; Ramachandran A; Sharp S; Westgate K; Brage S; Wareham N
    BMC Endocr Disord; 2018 Sep; 18(1):63. PubMed ID: 30200935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Mobile Text Messaging on Glycemic Control in Patients With Coronary Heart Disease and Diabetes Mellitus: A Randomized Clinical Trial.
    Huo X; Krumholz HM; Bai X; Spatz ES; Ding Q; Horak P; Zhao W; Gong Q; Zhang H; Yan X; Sun Y; Liu J; Wu X; Guan W; Wang X; Li J; Li X; Spertus JA; Masoudi FA; Zheng X
    Circ Cardiovasc Qual Outcomes; 2019 Sep; 12(9):e005805. PubMed ID: 31474119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for a randomised controlled trial of a co-produced, complex, health promotion intervention for women with prior gestational diabetes and their families: the Face-it study.
    Nielsen KK; Dahl-Petersen IK; Jensen DM; Ovesen P; Damm P; Jensen NH; Thøgersen M; Timm A; Hillersdal L; Kampmann U; Vinter CA; Mathiesen ER; Maindal HT;
    Trials; 2020 Feb; 21(1):146. PubMed ID: 32033613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of a Nine-Month Web- and App-Based Workplace Intervention to Promote Healthy Lifestyle and Weight Loss for Employees in the Social Welfare and Health Care Sector: A Randomized Controlled Trial.
    Balk-Møller NC; Poulsen SK; Larsen TM
    J Med Internet Res; 2017 Apr; 19(4):e108. PubMed ID: 28396303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Effectiveness of a Smartphone App Combined With a Smart Band on Weight Loss, Physical Activity, and Caloric Intake in a Population With Overweight and Obesity (Evident 3 Study): Randomized Controlled Trial.
    Lugones-Sanchez C; Recio-Rodriguez JI; Agudo-Conde C; Repiso-Gento I; G Adalia E; Ramirez-Manent JI; Sanchez-Calavera MA; Rodriguez-Sanchez E; Gomez-Marcos MA; Garcia-Ortiz L;
    J Med Internet Res; 2022 Feb; 24(2):e30416. PubMed ID: 35103609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.